Do patients with Parkinson's disease and mild cognitive impairment have different brain volumes?
Mild cognitive impairment (MCI) is common in Parkinson's disease (PD) and often precedes dementia. Researchers use MRI scans to measure brain volume and look for differences between PD patients with MCI (PD-MCI) and those with normal cognition (PD-NC). A 2025 meta-analysis found that PD-MCI is linked to smaller volumes in key brain regions involved in memory, movement, and emotion.
What the research says
A comprehensive meta-analysis pooled data from multiple MRI studies comparing brain volumes in PD-MCI versus PD-NC 4. It found significant bilateral atrophy (shrinkage) in the hippocampus, thalamus, putamen, and amygdala in PD-MCI patients 4. The right globus pallidus was also smaller, but the caudate nuclei were not significantly different 4. These findings suggest a distinct pattern of subcortical atrophy involving limbic and striatal circuits, which may help explain the cognitive decline 4. The results were robust across sensitivity analyses, and no publication bias was detected 4. This aligns with the Movement Disorder Society's diagnostic criteria, which recognize MCI as a high-risk state for dementia in PD 910.
What to ask your doctor
- Could an MRI scan help assess my risk of cognitive decline?
- What do changes in brain volume mean for my long-term prognosis?
- Are there any treatments or lifestyle changes that might slow brain volume loss?
- How often should I have cognitive testing to monitor for MCI?
- Should I be referred to a specialist for further evaluation of my memory or thinking?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.